Skip to main content

Table 10 Unadjusted estimated effect of treatment on hemorrhagic complications

From: Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

 

Unadjusted OR (95 % CI)

p-value

Fondaparinux vs. variable dose warfarin

Both

1.29 (0.61-2.71)

0.709

 

Hip

0.45 (0.14-1.42)

0.236

 

Knee

3.18 (1.07-9.45)

0.034

Fixed dose warfarin vs. variable dose warfarin

Both

0.83 (0.38-1.84)

0.854

 

Hip

0.38 (0.12-1.24)

0.134

 

Knee

1.78 (0.57-5.62)

0.463

Fixed dose warfarin vs. fondaparinux

Both

0.65 (0.30-1.40)

0.384

 

Hip

0.84 (0.23-3.10)

0.946

 

Knee

0.56 (0.21-1.47)

0.338